Meet Lophius at the 45th annual meeting of the EBMT
Lophius recently announced successful top-line results from its multicenter AlloProtect CMV clinical study in hematopoietic stem cell transplant recipients.
We would like to invite you now to the scientific talk of Dr. Eva Wagner-Drouet (Mainz, Germany) about the soon-to-be published AlloProtect CMV study results.
The oral presentation OS6-6 is part of the session "Oral Session 6 - Infectious diseases" held in "Conclusio 1+2" on March 26th, 02:55-03:06 pm.
Title of the talk: "Clinical validation of a novel ELISpot-based in vitro diagnostic assay: Monitoring cytomegalovirus-specific cell-mediated immunity and risk stratification in hematopoietic stem cell transplant recipient"
Interested to learn more about the capabilities of our CE-marked T-Track® CMV test in the field of hematopoietic stem cell transplantation?
You are welcome to meet Dr. Katharina Eder and Dr. Traudel Schmidt at booth B41 at the industry exhibition.